1/1

Ruxolitinib Rutinib Cream 1.5%

Balaji Pharma logo
Balaji Pharma
Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler — Bengaluru, Karnataka, India · Replies in ~24–48 hours
Export Ready
₹ 96.35 /Unit In stock
Inclusive of all taxes
MOQ: 1 Unit
Lead time: On request
GST invoice
Origin: India
Export ready
Buyer protection
Interested in this product?
Share your requirement and the seller will respond with a quote.
Comparing multiple suppliers?
Receive quotations from multiple verified suppliers and compare price & lead time.
Other buying options
Buyer-protected enquiry Seller responds in ~24–48 hours Freight & duties quoted separately
Export Snapshot
Minimum order
1 Unit
HSN Code
On request
Origin
India
Lead time
On request
Port of dispatch
On request
Packaging
Standard export packaging
Shelf life / storage
As per product specification
Export markets served
Global markets
Ability to customise
As per OEM brief
Values shown are for Balaji Pharma.
Company Balaji Pharma
Balaji Pharma logo
Balaji Pharma

Registered address: Bengaluru, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals › Health Care Products.

View profile →
Established
Not shared
Employees
–
GST
29AQTPJ8785C1Z2
IEC code
Not shared
Export markets
Global markets
Member since
Aug 2019
Turnover
$250,000 - $1 MM
Incorporation type
On request
Product details
Ruxolitinib Rutinib Cream 1.5% is a topical medication used to treat certain skin conditions such as atopic dermatitis (eczema) and vitiligo. Ruxolitinib, the active ingredient, is a Janus kinase (JAK) inhibitor that works by modulating the immune response, thereby reducing inflammation and skin depigmentation. The cream is applied directly to the affected areas as prescribed by a healthcare professional. Patients should follow the application guidelines to achieve optimal results and minimize potential side effects. Manufactured under strict quality controls, Ruxolitinib Rutinib Cream ensures safety and effectiveness for dermatological use.
Description provided by Balaji Pharma.

Ruxolitinib 1.5%

JAK enzyme inhibition to reduce skin inflammation and depigmentation

Atopic dermatitis (eczema), Vitiligo

Topical cream for direct skin application

Prescription-only medication

Produced under strict pharmaceutical quality controls

Apply to affected areas as directed by healthcare professional

Reduces inflammation, aids repigmentation, improves skin appearance

Requires medical supervision to minimize side effects

Cream tube consistent with dosage instructions

Specifications
Concentration
1.5% Ruxolitinib
Type of Medication
Topical immunomodulator
Therapeutic Class
JAK inhibitor
Indicated Skin Conditions
Atopic dermatitis (eczema), Vitiligo
Formulation Type
Cream
Application Method
Topical application on affected skin
Storage Requirements
Store below 30°C, protect from light and moisture
Shelf Life
Typically 2 years from manufacture date
Regulatory Status
Prescription drug as per Indian medical guidelines
Manufacturer Quality Standards
Complies with CGMP (Current Good Manufacturing Practice)
Use cases
Category
Pharmaceuticals > Dermatology > Topical Medications
Primary application
Brand
Not specified
Product type
Product
Logistics & handling
Lead time
On request
Packaging
As per buyer requirement
Storage condition
As recommended by supplier
Origin
India
Form
As listed by supplier
Commercials Balaji Pharma
Minimum order
1 Unit
Lead time
On request
Payment terms
As per negotiated commercial agreement
Frequently asked by buyers
What skin conditions is Ruxolitinib Rutinib Cream 1.5% primarily prescribed for?

Ruxolitinib Rutinib Cream 1.5% is primarily prescribed for inflammatory skin conditions such as atopic dermatitis (eczema) and pigmentary disorders like vitiligo.

How does Ruxolitinib Rutinib Cream 1.5% work on affected skin areas?

The cream works by inhibiting Janus kinase (JAK) enzymes involved in the immune and inflammatory pathways, reducing inflammation and promoting repigmentation by restoring skin pigment cells.

Is Ruxolitinib Rutinib Cream 1.5% safe for long-term use?

Long-term use safety should be determined by a healthcare provider, as continuous inhibition of JAK enzymes requires medical supervision to minimize potential side effects.

Can Ruxolitinib Rutinib Cream be applied to large skin areas?

Application should be limited to affected areas as prescribed by the healthcare professional; using the cream on large body surfaces should only be done under medical advice.

What are the storage conditions for Ruxolitinib Rutinib Cream 1.5%?

The cream should be stored below 30°C, away from direct sunlight and moisture to maintain its stability and effectiveness.

Question not answered? Sellers typically reply within 24–48 hours.

What similar products are available in this category?

Browse all →
panchagavya rollon balm
panchagavya rollon balm
Hetha
From $ 2.04
MOQ 1 Unit
triphala ghrita
triphala ghrita
Hetha
From $ 18.14
MOQ 1 Unit
tilt table without fowler bed GST VERIFIED
tilt table without fowler bed
Anantya Bionics
Price on request
MOQ 1 Unit
wireless ultrasound GST VERIFIED
wireless ultrasound
Anantya Bionics
Price on request
MOQ 1 Unit
neonatal ventilator GST VERIFIED
neonatal ventilator
Anantya Bionics
Price on request
MOQ 1 Unit
x-ray machine GST VERIFIED
x-ray machine
Anantya Bionics
Price on request
MOQ 1 Unit
phage gp 1 tab - dr precision GST VERIFIED
phage gp 1 tab - dr precision
Bluepill Express
From $ 2.48
MOQ 1 Piece
avanafil tablets 100mg - dr precision GST VERIFIED
avanafil tablets 100mg - dr precision
Bluepill Express
From $ 2.28
MOQ 1 Month
Ruxolitinib Rutinib Cream 1.5%
Ruxolitinib Rutinib Cream 1.5%
₹ 96.35 /Unit